S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Wall Street adds more to its big January after strong week
Italy's premier visits Libya for talks on energy, migration
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Wall Street adds more to its big January after strong week
Italy's premier visits Libya for talks on energy, migration
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Wall Street adds more to its big January after strong week
Italy's premier visits Libya for talks on energy, migration
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Wall Street adds more to its big January after strong week
Italy's premier visits Libya for talks on energy, migration
NASDAQ:OBSV

ObsEva - OBSV Stock Forecast, Price & News

$0.21
+0.01 (+4.94%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.20
$0.21
50-Day Range
$0.14
$0.21
52-Week Range
$0.13
$2.14
Volume
840,228 shs
Average Volume
498,066 shs
Market Capitalization
$16.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.40

ObsEva MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
3,851.1% Upside
$8.40 Price Target
Short Interest
Healthy
2.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of ObsEva in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.63) to ($0.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

462nd out of 1,055 stocks

Pharmaceutical Preparations Industry

222nd out of 519 stocks


OBSV stock logo

About ObsEva (NASDAQ:OBSV) Stock

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

OBSV Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
ObsEva Announces Dismissal of Moratorium Proceedings
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
ObsEva SA (OBSV)
See More Headlines
Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

OBSV Company Calendar

Last Earnings
12/01/2022
Today
1/28/2023
Next Earnings (Estimated)
3/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OBSV
Fax
N/A
Employees
48
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.40
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+3,851.1%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-58,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.41 per share

Miscellaneous

Free Float
N/A
Market Cap
$16.58 million
Optionable
Not Optionable
Beta
0.49

Key Executives

  • Brian O'Callaghan
    Chief Executive Officer & Director
  • William M. Brown
    Chief Financial Officer
  • Brandi Howard
    Chief Clinical Officer
  • Elke Bestel
    VP, Head-Drug Safety & Pharmacovigilance
  • Luigi Marro
    Chief Transformation Officer













OBSV Stock - Frequently Asked Questions

Should I buy or sell ObsEva stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ObsEva in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OBSV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OBSV, but not buy additional shares or sell existing shares.
View OBSV analyst ratings
or view top-rated stocks.

What is ObsEva's stock price forecast for 2023?

5 Wall Street analysts have issued twelve-month price targets for ObsEva's stock. Their OBSV share price forecasts range from $1.00 to $12.00. On average, they predict the company's share price to reach $8.40 in the next twelve months. This suggests a possible upside of 3,851.1% from the stock's current price.
View analysts price targets for OBSV
or view top-rated stocks among Wall Street analysts.

How have OBSV shares performed in 2023?

ObsEva's stock was trading at $0.1450 at the beginning of 2023. Since then, OBSV stock has increased by 46.6% and is now trading at $0.2126.
View the best growth stocks for 2023 here
.

Are investors shorting ObsEva?

ObsEva saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,050,000 shares, a decline of 37.1% from the December 31st total of 1,670,000 shares. Based on an average daily volume of 1,710,000 shares, the days-to-cover ratio is currently 0.6 days. Currently, 2.5% of the company's shares are sold short.
View ObsEva's Short Interest
.

When is ObsEva's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our OBSV earnings forecast
.

How were ObsEva's earnings last quarter?

ObsEva SA (NASDAQ:OBSV) released its quarterly earnings data on Thursday, December, 1st. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.01.

What other stocks do shareholders of ObsEva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Trevena (TRVN), Zosano Pharma (ZSAN), Vaxart (VXRT), VBI Vaccines (VBIV), Bionano Genomics (BNGO) and ADMA Biologics (ADMA).

When did ObsEva IPO?

(OBSV) raised $98 million in an IPO on Thursday, January 26th 2017. The company issued 6,500,000 shares at a price of $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

What is ObsEva's stock symbol?

ObsEva trades on the NASDAQ under the ticker symbol "OBSV."

How do I buy shares of ObsEva?

Shares of OBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ObsEva's stock price today?

One share of OBSV stock can currently be purchased for approximately $0.21.

How much money does ObsEva make?

ObsEva (NASDAQ:OBSV) has a market capitalization of $16.58 million and generates $20.11 million in revenue each year. The company earns $-58,380,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis.

How can I contact ObsEva?

ObsEva's mailing address is Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228. The official website for the company is www.obseva.com. The company can be reached via phone at (122) 552-3840 or via email at ir@obseva.ch.

This page (NASDAQ:OBSV) was last updated on 1/28/2023 by MarketBeat.com Staff